ORKA
ORKA clinical trials: Oruka Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Oruka Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 8
- Trials linked
- 8
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ORKA on the catalyst calendar · ORKA registry changes
- Primary completion Jul 1, 2029Sponsor estimatePhase 2NCT07933783An Open-label Study With Maintenance Dosing of ORKA-002 in Participants With Moderate-to-Severe Plaque PsoriasisOruka Therapeutics, Inc. · Plaque PsoriasisEnrolling by invitationORKALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 21, 2026ActualPhase 2NCT07290569Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque PsoriasisOruka Therapeutics, Inc. · Plaque PsoriasisActive, not recruitingORKALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2028Sponsor estimatePhase 2NCT07783542ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis SuppurativaOruka Therapeutics, Inc. · Hidradenitis Suppurativa (HS)RecruitingORKALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2030Sponsor estimatePhase 2NCT07449702An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisOruka Therapeutics, Inc. · Plaque PsoriasisRecruitingORKALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2027Sponsor estimatePhase 2NCT07474792Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisOruka Therapeutics, Inc. · Plaque PsoriasisActive, not recruitingORKALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 20, 2026ActualPhase 1NCT06944379ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single DoseOruka Therapeutics, Inc. · Healthy VolunteersCompletedORKALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 25, 2026ActualPhase 2NCT07090330ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisOruka Therapeutics, Inc. · Plaque PsoriasisActive, not recruitingORKALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 13, 2026ActualPhase 1NCT06698939ORKA-001 in Healthy VolunteersOruka Therapeutics, Inc. · Healthy VolunteersCompletedORKALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner